BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 33159022)

  • 1. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
    Li Z; Li F; Peng Y; Fang J; Zhou J
    Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.
    Du Y; Hou G; Zhang H; Dou J; He J; Guo Y; Li L; Chen R; Wang Y; Deng R; Huang J; Jiang B; Xu M; Cheng J; Chen GQ; Zhao X; Yu J
    Nucleic Acids Res; 2018 Jun; 46(10):5195-5208. PubMed ID: 29506078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Dig Dis Sci; 2021 Apr; 66(4):1110-1126. PubMed ID: 32333311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
    Yang Y; Qian Cai Q; Sheng Fu L; Wei Dong Y; Fan F; Zhong Wu X
    Chem Biodivers; 2022 Nov; 19(11):e202200333. PubMed ID: 36149370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
    Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
    Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T
    Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.
    Li Q; Li X; Tang H; Jiang B; Dou Y; Gorospe M; Wang W
    J Cell Biochem; 2017 Sep; 118(9):2587-2598. PubMed ID: 28247949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity.
    Dou X; Huang L; Xiao Y; Liu C; Li Y; Zhang X; Yu L; Zhao R; Yang L; Chen C; Yu X; Gao B; Qi M; Gao Y; Shen B; Sun S; He C; Liu J
    Protein Cell; 2023 Sep; 14(9):683-697. PubMed ID: 37030005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3.
    Meiser N; Mench N; Hengesbach M
    Biol Chem; 2020 Nov; 402(1):89-98. PubMed ID: 33544495
    [No Abstract]   [Full Text] [Related]  

  • 18. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 and METTL14-mediated N
    Shen L; Zhang C; Zhang Y; Yang Y
    Reprod Biomed Online; 2023 Feb; 46(2):255-265. PubMed ID: 36517319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated m6A modification is required for cerebellar development.
    Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
    PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.